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Introduction
Most of the 51 species embedded in the genus Sporothrix are nonpathogenic environmental
fungi that are closely related to decaying wood, plants, and soil. However, members of the
Sporothrix schenckii complex are highly successful mammal pathogens, including S. brasilien-
sis, S. schenckii sensu stricto (s. str.), S. globosa, and S. luriei, the causative agents of human and
animal sporotrichosis [1]. Their key to success during mammal infection lies at least in part
with their ability to change from a mycelial saprophytic lifestyle at 25˚C in the environment to
a parasitic yeast cell at an elevated temperature (35˚C–37˚C), such as those developed by
warm-blooded hosts [2].
Typically, infection develops after traumatic inoculation of contaminated soil, plants, and
organic matter into skin or mucosa. Alternatively, infection may occur during the animal
transmission (cat–cat or cat–dog) and zoonotic transmission (cat–human), which has been
mostly associated with scratches or bites from infected cats [2]. In Brazil, S. brasiliensis is
repeatedly associated with feline infection and has consistently shown higher virulence during
epizootics, as well as in murine models of sporotrichosis. A hallmark of S. brasiliensis infection
is its tendency to escalate to outbreaks or epidemics among cats with high potential for zoo-
notic transmission.
Sporotrichosis is an emergent disease and, over the past two decades, the incidence of zoo-
notic sporotrichosis has been on the rise, particularly in Brazil. Judging from the epizootic and
zoonotic epidemics taking place in Rio de Janeiro, Brazil, tackling sporotrichosis requires the
engagement of animal and human health policies to reduce the transmission chain of
Sporothrix.
Infected Cat: Key Point in Zoonotic Transmission
Cat-transmitted sporotrichosis has been documented in isolated cases or in small outbreaks in
the American and Asian continents. Interestingly, although isolated cases of feline sporotri-
chosis have been documented in Australia, Spain, Japan, and Germany, there are no reports of
zoonotic transmission from these regions [3–6] (Fig 1A).
In the United States, isolated cases or small outbreaks were reported from 1952 to 2011,
and S. schenckii was the etiologic agent [7–9]. In Mexico, where the predominant etiologic
agent is S. schenckii s. str. [10], only one case of zoonotic sporotrichosis was described related
to a scratch of an infected cat in 2008 [11].
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Between 2011 and 2014, four cases of human sporotrichosis related to cats were reported in
Buenos Aires, Argentina. To our knowledge, this is the first report of zoonotic sporotrichosis
in this country [12]. Even though the causative species has not yet been reported, the proximity
to the Southern region of Brazil and the type of transmission suggests that S. brasiliensis may
be the species involved in these cases.
In Malaysia, 12 cases of zoonotic transmission related to cats were reported between 1990
and 2010, and five of them were from a small outbreak [13–14]. Recently, 18 clinical isolates
from cats in Malaysia were identified as S. schenckii s. str., the prevailing causative agent of the
feline sporotrichosis in this country [10]. In India, one case of zoonotic transmission was
reported in 2009, and samples from the patient and his cat were positive for S. schenckii s. str.
[15].
Although cats are a source of infection and a key to transmission, the evaluation of the
feline population in endemic areas were performed in Brazil and Peru [16–17]. Curiously, in
an endemic region in Peru, where zoonotic transmission was not recorded, Sporothrix was iso-
lated from the nasal cavity and/or nails of two cats (2.38%) without clinical signs of sporotri-
chosis [17].
An Unprecedent Zoonotic Epidemic
From 1997 to 2011, 4,188 human cases were recorded at Oswaldo Cruz Foundation (Fiocruz),
Rio de Janeiro, the main referral center for the treatment of this mycosis in Brazil [18]. Since
1998, 244 dogs were diagnosed through 2014 [19], and 4,703 cats were diagnosed through
2015. Due to the high incidence of feline sporotrichosis, Rio de Janeiro is presently considered
hyperendemic for cat-associated sporotrichosis [2]. However, these cases were recorded from
only one institution, so they do not truly reflect the actual picture of this disease in this region.
Cases of feline sporotrichosis and zoonotic transmission have been reported in other Brazilian
states, especially in Rio Grande do Sul and São Paulo; however, the reported number in these
regions is much smaller compared to Rio de Janeiro [2] (Fig 1B). Despite the fact that this is
the largest number of canine sporotrichosis cases ever documented, there were no reports
of zoonotic transmission from dogs in the Rio de Janeiro epidemic. Dogs are not directly
involved in the transmission of the Sporothrix spp., probably due to the scarcity of fungal
organisms in their lesions in the majority of the cases [20].
Overcoming Drug Resistance: A Treatment Challenge
Treatment usually requires long-term administration of itraconazole, potassium iodide, or
amphotericin B, depending on the severity and location of the lesions. Genotyping of Sporo-
thrix during cat-transmitted sporotrichosis associated with antifungal susceptibility profiles
raised concern for the emergence and spread of drug-insensitive strains [21–22]. Remarkably,
studies reported an increasing number of amphotericin B and itraconazole-insensitive strains
over time [21]. Identifying these epidemiological trends associated with the emergence of drug
resistance is important to adjust antifungal therapy and to encourage the development of new
drugs to treat sporotrichosis. Currently, potential alternative therapies to impair Sporothrix
development and tackle sporotrichosis include terpinen-4-ol and farnesol [23], miltefosine
[24], TCAN26 (a structural analogue of miltefosine) [25], and H3 (a 24-sterol methyltransfer-
ase inhibitor) [26].
Successful treatment outcomes will also rely on rapid and accurate diagnosis, especially
when dissimilar antifungal susceptibility profiles are noted among different Sporothrix species.
A cost-effective option includes the molecular diagnosis based on species-specific PCR using
primers targeting the calmodulin-encoding gene from pathogenic Sporothrix. This PCR-based
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Fig 1. Feline sporotrichosis cases around the world, 1952–2016. (A) Since the mid-20th century, feline sporotrichosis has typically occurred in isolated
cases and small outbreaks, and only a few reports of zoonotic transmission have been described in the literature. The Southeast Brazil region has the largest
absolute number of cases with an overwhelming prevalence of S. brasiliensis during epizootic outbreaks. Outside Brazil, most feline cases are due to the
classical agent S. schenckii. (B) Spatiotemporal evolution of feline sporotrichosis cases in Brazil. Over the last two decades (1998–2016), Brazil has
experienced a long-lasting outbreak of cat-transmitted sporotrichosis in Rio de Janeiro, with 4,669 cases reported. Cat-borne sporotrichosis due to S.
brasiliensis often appears in the form of outbreaks or epidemics within a short period of time. Remarkably, before the 1990s, Rio de Janeiro reported a low
number of cases, nearly always unrelated to feline transmission types.
doi:10.1371/journal.ppat.1006077.g001
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method is able to detect Sporothrix DNA with high sensitivity and specificity from infected
specimens even in the presence of DNA from the warm-blooded host [27].
A Highly Virulent Pathogen Meets a Susceptible Host
Cell-mediated immunity is thought to play an important role in the control of feline sporotri-
chosis, since increased percentages of CD4 cells are correlated with single lesions, well-orga-
nized inflammation, and lower fungal burden. However, most cats with sporotrichosis display
lesions with poorly-formed granulomas and high fungal burden, which generally correlated
with CD8low cell subsets [28]. Interestingly, this subset is referred to as greatly enhanced by a
Th2-shifted environment [29], while the host protective immunity to fungal infections seems
to rely largely on a Th1-biased response [30]. Still, the underlying mechanisms leading to dif-
ferent presentations of feline sporotrichosis are undetermined.
Severe feline sporotrichosis may develop independently of retrovirus coinfections, which
are known to cause immunosuppression in cats. In most of the endemic areas of Rio de
Janeiro, the cats are usually allowed to roam outdoors, and most of them are not vaccinated
nor neutered and do not receive regular prophylactic deworming. Therefore, the population of
stray cats is large, and the contribution of other infectious diseases to the susceptibility of cats
to sporotrichosis cannot be ruled out. In fact, fungal and parasitic infections elicit conflicting
immune pathways that may counterbalance each other. In contrast to the antifungal immu-
nity, the classical defense mechanisms to helminth infections include increase of IL-10 and
Th2 cytokines, with the suppression of Th1 cytokines [31]. Therefore, we expect this kind of
parasite–Sporothrix coinfection to increase susceptibility to sporotrichosis. Accordingly,
changes in cytokine profile and the lack of fungal clearance are reported in rats with experi-
mental sporotrichosis coinfected by Taenia taeniaeformis [32]. We have no clear information
about which cytokines drive mechanisms of immune response in cats with sporotrichosis and
whether helminth coinfection shifts the inflammatory environment. Even so, we hypothesize
that helminth infection control in cats with sporotrichosis could balance the immune response
in favor of a Th1 type and contribute to the fungal clearance with a reduction on their zoonotic
potential.
It is also possible that an increased virulence of S. brasiliensis may be a factor contributing
to the sporotrichosis outbreak in Rio de Janeiro. Experimental model systems from mice to
invertebrates have been used to investigate the emergence of pathogenicity of Sporothrix and
bring attention to differences in pathology and virulence factors, where S. brasiliensis usually
display higher fungal burden, invasiveness, and extensive tissue damage when compared to the
remaining agents in the S. schenckii complex [33]. In support of this hypothesis, an increasing
virulence of S. brasiliensis over the years of infection was reported in a patient and assigned to
improve fungal resistance to host’s oxidative stress [34].
Recently, the distinct sensititivities to oxidative stress between S. brasiliensis and S. schenckii
were correlated with the Hog-1 stress-induced kinase pathway [35]. The production of mela-
nin is also associated with resistance to phagocytosis in more pathogenic isolates of Sporothrix,
notably to S. brasiliensis [36]. Cell wall lipids are also able to inhibit the phagocytosis [37], and
yeasts of Sporothrix are more virulent than longer-term culture conidia, which is thought to
reflect enhanced evasion of phagocytosis [38]. Unlike classic transmission of Sporothrix, due to
inoculation of asexual spores, zoonotic transmission is thought to be mediated by yeast cells.
Innate immunity plays a role in the development of adaptive response, by recognizing fungal
wall elements through Toll-like receptors [37]. Thus, the direct inoculation of yeast could lead to
more challenging host–pathogen interactions and be crucial for the establishment of the infec-
tion. We speculate that the evasion of the yeast cells could take part in the typical development
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of lesions [28] with macrophages apparently unable to complete phagocytosis in feline sporotri-
chosis and prevent further activation of adaptive immunity. Fungal wall compounds are also
important in the adhesion to extracellular matrix, in particular 3-carboxymuconate cyclase (gly-
coprotein Gp70 and Gp60) [39–40]. The glycoprotein Gp60 has also been suggested to act as a
virulence factor, as it is associated with more virulent isolates of Sporothrix, principally S. brasi-
liensis [40].
Vaccine Candidates and Perspectives
A specific and protective humoral response against Sporothrix has already been observed [40–
41] and may be a clue for the further investigation of vaccine candidates. Sporothrix 3-carboxy-
muconate cyclase has emerged as a potential target for vaccination studies [40,42]. Since both
Gp70 and Gp60 are recognized by antibodies in serum from cats with sporotrichosis [40], and
considering that these cats are a potent and major source of Sporothrix in Brazilian epidemics,
an effective vaccine to prevent their infection or control their fungal burden would be a princi-
pal measure to reduce transmission.
Studies to identify a vaccine candidate and the ideal adjuvant are ongoing [40,43]. Promis-
ing results using S. schenckii cell wall protein in an aluminum hydroxide (AH) adjuvanted for-
mulation have been reported [43]. However, the use of AH as an adjuvant should be carefully
reviewed for future studies in cats, since this compound is involved in feline vaccine-induced
sarcomas [44]. Passive immunization or the nonadjuvanted formulation should therefore be
studied initially. Even though, the recent progress in the search for vaccine antigens and adju-
vants herein discussed is encouraging especially as an important aid for controlling the enor-
mous health burden of feline sporotrichosis in endemic areas [42]. Therefore, we raise the cats
as the key host for further vaccine investigations.
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